In addition, Byun et al. revealed that EGCG modulates Toll-like signaling pathway via suppressing the expression of 67-kDa laminin receptor (67LR) and downregulating TLR2 and TLR4 on dendritic and leukemia cells [19,20]. The gene discussed is TLR2; the disease is leukemia.